THE EFFECTS OF AROMATIC AND ALIPHATIC MALEIMIDE CROSSLINKERS ON ANTI-CD5 RICIN IMMUNOTOXINS

被引:15
|
作者
MYERS, DE
UCKUN, FM
SWAIM, SE
VALLERA, DA
机构
[1] UNIV MINNESOTA HOSP & CLIN,DEPT THERAPEUT RADIOL,BOX 367,HARVARD ST & E RIVER RD,MINNEAPOLIS,MN 55455
[2] UNIV MINNESOTA HOSP & CLIN,EXPTL CANC IMMUNOL SECT,MINNEAPOLIS,MN 55455
关键词
D O I
10.1016/0022-1759(89)90428-6
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
引用
收藏
页码:129 / 142
页数:14
相关论文
共 50 条
  • [21] COMPARISON OF ACTIVITY OF ANTI-CD25 IMMUNOTOXINS CONTAINING RICIN AND MISTLETOE LECTIN-I A-CHAIN
    TONEVITSKII, AG
    AGAPOV, II
    SHAMSHIEV, AT
    BUSHUEVA, TL
    KERNER, ID
    KOPP, J
    PFULLER, U
    DOKLADY AKADEMII NAUK, 1994, 339 (03) : 407 - 409
  • [22] THE EVALUATION OF 4 ANTI-HUMAN CD22 ANTIBODIES AS RICIN A CHAIN-CONTAINING IMMUNOTOXINS (IT-AS)
    SHEN, GL
    LI, JL
    GHETIE, MA
    MAY, R
    TILL, M
    UHR, JW
    AMLOT, P
    JANOSSY, G
    VITETTA, ES
    THORPE, P
    FASEB JOURNAL, 1988, 2 (04): : A692 - A692
  • [23] IMMUNOLOGICAL ASSESSMENT DURING TREATMENT OF RHEUMATOID-ARTHRITIS WITH ANTI-CD5 IMMUNOCONJUGATE
    CANNON, GW
    MARBLE, DA
    GRIFFITHS, MM
    COLE, BC
    MCCALL, S
    SCHULMAN, SF
    STRAND, V
    JOURNAL OF RHEUMATOLOGY, 1995, 22 (02) : 207 - 213
  • [24] Pretreatment of kidney allografts with anti-CD5 immunotoxin (IT) in cases of poor HLA histocompatibility
    Dolbin, A
    Alexeev, L
    Khaitov, R
    Sechkin, A
    Toptygin, A
    Korenkova, E
    Moisjuk, Y
    Tonevitsky, A
    Shumakov, V
    HUMAN IMMUNOLOGY, 1996, 47 (1-2) : P901 - P901
  • [25] BLOCKED RICIN-CONJUGATED-T CELL IMMUNOTOXINS - EFFECT OF ANTI-CD6-BLOCKED RICIN ON NORMAL-T CELL-FUNCTION
    RASMUSSEN, RA
    COUNTS, SL
    LAMBERT, JM
    COLLINSON, AR
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 1992, 35 (05) : 355 - 363
  • [26] CYCLIC ANTI-CD5 IMMUNOCONJUGATE THERAPY IN EARLY RHEUMATOID-ARTHRITIS (RA)
    CUSH, J
    OLSEN, NJ
    BROOKS, RH
    NICHOLS, LA
    KAVANAUGH, AF
    LIPSKY, PE
    ARTHRITIS AND RHEUMATISM, 1993, 36 (09): : S130 - S130
  • [27] Anti-CD5 extends the proliferative response of human CD5(+) B cells activated with anti-IgM and interleukin-2
    Jamin, C
    LeCorre, R
    Lydyard, PM
    Youinou, P
    EUROPEAN JOURNAL OF IMMUNOLOGY, 1996, 26 (01) : 57 - 62
  • [28] ANTIGENIC MODULATION INDUCED BY 4 MONOCLONAL-ANTIBODIES ADSORBED ON GOLD PARTICLES (SPECIFICITY ANTI-CD4, ANTI-CD5, ANTI-CD7, AND ANTI-150-KDA ANTIGEN) - RELATIONSHIP BETWEEN MODULATION AND CYTO-TOXIC ACTIVITY OF IMMUNOTOXINS
    CARRIERE, D
    ARCIER, JM
    DEROCQ, JM
    FONTAINE, C
    RICHER, G
    EXPERIMENTAL CELL RESEARCH, 1989, 182 (01) : 114 - 128
  • [29] EFFECTS OF AN ANTI-CD5 IMMUNOCONJUGATE (CD5-PLUS) IN RECENT-ONSET TYPE-I DIABETES-MELLITUS - A PRELIMINARY INVESTIGATION
    SKYLER, JS
    LORENZ, TJ
    SCHWARTZ, S
    EISENBARTH, GS
    EINHORN, D
    PALMER, JP
    MARKS, JB
    GREENBAUM, C
    SARIA, EA
    BYERS, V
    JOURNAL OF DIABETES AND ITS COMPLICATIONS, 1993, 7 (04) : 224 - 232
  • [30] ANTI-CD5 RICIN A CHAIN IMMUNOTOXIN DECREASES ACUTE GRAFT-VS-HOST DISEASE (GVHD) AFTER UNRELATED DONOR MARROW TRANSPLANTATION (MUD BMT)
    PRZEPIORKA, D
    VONWOLFF, B
    IPPOLITI, C
    DEISSEROTH, AB
    GIRALT, S
    LASKER, J
    ANDERSSON, BS
    FISCHER, HE
    CHAMPLIN, RE
    EXPERIMENTAL HEMATOLOGY, 1992, 20 (06) : 709 - 709